“Xenobot” Living Robots Can Reproduce

Biological robots made from frog cells can replicate by smooshing loose cells into new robots—a reproduction method not seen in any other organism.

Written byChloe Tenn
Published Updated 3 min read
colored microscope image of xenobot
Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Xenobots—living robots made from the stem cells of the African frog (Xenopus laevis)—had already impressed researchers by moving, healing themselves, and even spontaneously piling up debris that was strewn about. But when those small synthetic particles were replaced with loose frog cells, the little living bots did something remarkable: Xenobots “reproduced” by bringing those loose cells together, constructing new xenobots.1

“These are frog cells replicating in a way that is very different from how frogs do it. No animal or plant known to science replicates in this way,” Harvard University synthetic biologist and roboticist Sam Kriegman, co-lead author on the PNAS paper describing the discovery, said in a press release from Harvard University’s Wyss Institute.

Xenobots were first born when scientists extracted skin stem cells from frog embryos and cultured them in salt water. All on their own, the cells clumped together and cells on the outside of these clumps ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Related Topics

Meet the Author

  • young woman smiling

    Chloe Tenn is a graduate of North Carolina State University, where she studied neurobiology, English, and forensic science. Fascinated by the intersection of science and society, she has written for organizations such as NC Sea Grant and the Smithsonian. Chloe also works as a freelancer with AZoNetwork, where she ghostwrites content for biotechnology, pharmaceutical, food, energy, and environmental companies. She recently completed her MSc Science Communication from the University of Manchester, where she researched how online communication impacts disease stigma. You can check out more of her work here.

    View Full Profile
Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Graphic of amino acid chains folded into proteins

Expi293™ PRO Expression System: Higher Yields Across a Wider Variety of Proteins

Thermo Fisher Logo